Get 30% off on our Global Market Reports with code ONLINE30 – Hurry, limited time offer!
How Fast Is The Juvenile Idiopathic Arthritis Diagnostic Market Expected to Grow Between 2025 And 2029?
The market for diagnosing juvenile idiopathic arthritis has seen significant expansion in recent times. The market value is projected to increase from $4.75 billion in 2024 to $5.04 billion in 2025, reflecting a compound annual growth rate (CAGR) of 6.1%. The aforementioned growth in the historic period is a result of a rise in reported cases of juvenile idiopathic arthritis, an increase in cognizance of pediatric autoimmune conditions, early diagnosis, augmentation in healthcare funding, and an enhanced emphasis on child healthcare.
Over the coming years, the juvenile idiopathic arthritis diagnostic market is forecasted to flourish at a significant rate. By 2029, this market is projected to be worth $6.32 billion with a compound annual growth rate (CAGR) of 5.8%. This predicted expansion within the period is due to various contributing factors including amplified collaboration among research institutions, escalating demand for early and precise diagnostic options, a rise in the prevalence of autoimmune and inflammatory ailments, initiatives by governmental and healthcare organizations, and the emergence of telemedicine and digital health platforms. Technological progression, improvements in diagnostic technologies, bespoke treatment plans, and groundbreaking diagnostic tools are set to be the significant trends within this forecast period.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=23432&type=smp
Which Factors and External Forces Are Driving Demand in the Juvenile Idiopathic Arthritis Diagnostic Market?
The rise in autoimmune disorders is predicted to drive the growth of the juvenile idiopathic arthritis diagnostic market. Autoimmune disorders occur when the body’s immune system targets its own healthy cells, leading to inflammation, tissue harm, and ongoing health issues. The growth in these diseases is credited to a complex synergy of environmental factors, genetic inclinations, and changes in lifestyle. In juvenile idiopathic arthritis (JIA), these autoimmune diseases set off the immune system to erroneously target the synovial tissue in the joints, resulting in inflammation and damage. For instance, as per data from Versorgungsatlas.de, a Germany-based interactive online platform, in 2022, of 73,241,305 insured people, 6,304,340 were identified with at least one autoimmune disease. This exhibited a raw prevalence rate of 8.61% in November 2024. Thus the expanding prevalence of autoimmune disorders is propelling the juvenile idiopathic arthritis diagnostic market’s expansion.
Which Segments in the Juvenile Idiopathic Arthritis Diagnostic Offer the Most Growth?
The juvenile idiopathic arthritis diagnostic market covered in this report is segmented –
1) By Type: Serological Tests, Imaging Tests, Genetic Tests
2) By Technology: Molecular Diagnostics, Immunoassays, Flow Cytometry
3) By Services: Diagnostic Services, Consultation Services, Laboratory Services
4) By Application: Hospital Laboratories, Diagnostic Centres, Research Institutes
Subsegments:
1) By Serological Tests: Rheumatoid Factor (RF) Test, Antinuclear Antibody (ANA) Test, Erythrocyte Sedimentation Rate (ESR) Test, C-Reactive Protein (CRP) Test, Anti-Cyclic Citrullinated Peptide (Anti-CCP) Test, Complete Blood Count (CBC)
2) By Imaging Tests: X-Ray, Magnetic Resonance Imaging (MRI), Ultrasound, Computed Tomography (CT) Scan, Bone Scintigraphy (Bone Scan)
3) By Genetic Tests: HLA-B27 Genetic Marker Test, Whole Exome Sequencing (WES), Next-Generation Sequencing (NGS), Polymerase Chain Reaction (PCR)-Based Testing
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=23432&type=smp
What Are the Fastest-Growing Geographies in the Juvenile Idiopathic Arthritis Diagnostic Market?
North America was the largest region in the juvenile idiopathic arthritis diagnostic market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the juvenile idiopathic arthritis diagnostic market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
What Are the Current Market Growth and Trends in the Juvenile Idiopathic Arthritis Diagnostic Industry?
Leading firms in the juvenile idiopathic arthritis diagnostic market are adopting strategic alliances as a method to broaden their product range, enhance research prowess, and consolidate their global market standing. These tactical collaborations between organizations are designed to encourage early detection and diagnosis. A good example of this is the partnership in November 2024 between Augurex Life Sciences Corp., a biotech firm hailing from Canada, and the US-based Quest Diagnostics. Their common goal is to advance the diagnosis and treatment of rheumatoid arthritis (RA) by utilizing the 14-3-3η (eta) biomarker. As part of this cooperative effort, Quest Diagnostics is set to validate and provide a lab-developed test in the United States, founded on Augurex’s 14-3-3η biomarker. The test aims to identify increased amounts of the 14-3-3η protein, an indicator of rheumatoid arthritis that correlates with more severe disease and increased likelihood of joint damage.
View the full report here:
What Are the Key Elements That Define the Juvenile Idiopathic Arthritis Diagnostic Market?
Juvenile idiopathic arthritis (JIA) diagnostic refers to the medical processes and tests used to identify JIA, a chronic autoimmune condition in children that causes persistent joint inflammation, pain, and stiffness, potentially leading to long-term joint damage and mobility issues. It is caused by an overactive immune system mistakenly attacking the body’s own joint tissues due to genetic and environmental factors, triggering inflammation that, if left untreated, can result in growth complications, vision problems, and reduced quality of life.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=23432
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model